Bringing the fundamentals into focus…
Back to ADC Therapeutics SA
How ADC Therapeutics SA stacks up
ADCT · against 232 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #150 of 233 · scores higher than 10% of peers
Bars: peers in each 10-point band of the valuation score84 peers with a valuation score of 0–9, including ADCT · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its free cash flow yield, earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -53.1% vs peer median 0.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -50.3% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -22.5% vs peer median 4.0%
Metric by metric
Position: dot = ADCT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ADCT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 217 reported | -38.7% | -3.2% | 20% | 30% | |
| EBITDA yieldHigher is better · 239 reported | -22.5% | 1.3% | 22% | 50% | |
| Free cash flow yieldHigher is better · 140 reported | -51.7% | -12.4% | 15% | 20% | |
| Book yieldHigher is better · 221 reported | -115.5% | 61.3% | 2% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around ADCT| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 150 | 3.4B TWD (≈$106M) | 8 | 36 | |
| 150 | 7.2B TWD (≈$224M) | 8 | 41 | |
| 150 | 1.4B MYR (≈$309M) | 8 | 31 | |
| 150 | 243M USD | 8 | 27 | |
| 150 | 198M USD | 8 | 10 | |
| 150 | 201M USD | 8 | 24 | |
| 150 | 387M USD | 8 | 49 | |
| 150 | 271M USD | 8 | 14 | |
| 150 | 115M USD | 8 | 8 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score